East Yorkshire-headquartered Croda International has received US government backing to deliver a £108 million manufacturing facility to support vaccine production.
The smart science firm, already developing a similar project in the UK, has entered into an agreement that will see more than £60 million provided by the Biden administration.
It will be used to expand the country’s capacity for making lipid systems used in novel therapeutic drugs, such as mRNA vaccines. It is the solution used to carry the active ingredient into the body, and is used to ward off flu and treat cancer.
